RxDoctor Payments Data

Robert Ulrich

Neurology · Frisco, TXNPI 1215982699

Payments from drug & device makers

$13,378in general payments, 2019–2025

Across 795 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Biogen$1K
  • Novartis$880
  • Amgen$853
  • EMD Serono, Inc.$661
  • UCB, Inc.$592
  • plus $8K from 54 others

What the payments were for

  • Speaking & faculty fees$1141%
  • Food & beverage$13,20699%
  • Education$580%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)103$1,069
Biogen51$1,062
Novartis55$880
Amgen(2 entities)42$853
EMD Serono, Inc.44$661
UCB, Inc.36$592
Upsher-smith Laboratories LLC26$591
Sanofi31$527
Supernus Pharmaceuticals, Inc.65$477
Lilly USA, LLC28$397
Neurocrine Biosciences, Inc.15$340
Genentech USA, Inc.15$302
Acorda Therapeutics, Inc14$299
AstraZeneca13$289
Tanabe Pharma America, Inc.21$268
Eisai Inc.13$254
Acadia Pharmaceuticals Inc14$244
Teva Pharmaceuticals USA, Inc.15$230
Amneal Pharmaceuticals LLC11$220
Merz North America, Inc.6$208
Grifols USA, LLC10$200
Jazz Pharmaceuticals Inc.10$194
MDD US Operations, LLC7$192
SK Life Science, Inc.8$183
Assertio Therapeutics, Inc.12$182
Lundbeck LLC9$174
Kyowa Kirin, Inc.7$151
Promius Pharma LLC3$148
Adamas Pharmaceuticals, Inc.8$147
Livanova USA, Inc.7$140
Merz Pharmaceuticals, LLC4$134
Banner Life Sciences, LLC6$114
Abbott4$110
Bausch Health US, LLC5$108
CSL Behring6$101
Currax Pharmaceuticals LLC6$90
Johnson & Johnson5$85
Octapharma USA, Inc.1$83
Pfizer4$82
Avanir Pharmaceuticals, Inc.5$81
Arbor Pharmaceuticals, Inc.4$75
Bristol Myers Squibb4$72
Aquestive Therapeutics, Inc.4$71
Mallinckrodt Enterprises LLC3$71
Scilex Pharmaceuticals Inc.4$65
Collegium Pharmaceutical, Inc.3$57
Alnylam Pharmaceuticals Inc.3$54
Ipsen Biopharmaceuticals, Inc2$45
E.r. Squibb & Sons, L.L.C.3$38
Neurelis, Inc.2$36
Boston Scientific2$31
Argenx US, Inc.1$30
ANI Pharmaceuticals, Inc.1$26
Xeris Pharmaceuticals, Inc.1$25
Brainsway USA Inc1$23
Merck1$19
Almatica Pharma LLC1$19
Biohaven Pharmaceutical Holding Company Ltd.1$19
Takeda Pharmaceuticals U.S.A., Inc.1$18
Zyla Life Sciences, Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,378 in reported general payments places this provider in the 70th percentile of 1,246 neurology providers in Texas.

See all neurology providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl11$2,127
Gabapentin21$404
Methocarbamol15$404
Hydroxyzine Pamoate16$253
Quetiapine Fumarate14$228
Doxepin Hcl12$223
Tizanidine Hcl12$193
Trazodone Hcl29$171
Prazosin Hcl11$53

Paid to pharmacies, not to this prescriber.

Other neurology in Frisco

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →